News and Trends 19 Jan 2016
Top 8 Deadliest Cancers and their Potential Cures
…have Big Shots, like Bristol-Myers Squibb, with a PD-1 immune checkpoint inhibitor ‘Nivolumab’ (granted EU market authorization last July), followed closely by MSD’s Keytruda. Roche (Switzerland) also has Atezolizumab, which…
